sales@scalarmarketresearch.com |  +1-800-213-5170  (U.S./ Canada Toll-free) |  REGISTER |  SIGN IN

Home >> Reports >> gastrointestinal diseases market

report

Gastrointestinal Diseases Market, by Drug Category (Antacid & Anti-Ulcerant, GIT Anti-inflammatory, Antiemetic, Anti-diarrhoea and Other GIT Therapeutics) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2022

HC115 October 2016 100+ FREE 10% CUSTOMIZATION

Gastrointestinal Diseases Market is expected to grow from USD 17.27 billion in 2016 and reach USD 19.79 billion in 2022, growing at a CAGR of 2.3% during the forecast period.

Our industry experts anticipate that within the gastrointestinal diseases market, the GIT Anti-inflammatory drug will grow at the fastest CAGR ranging from 1% to .5%, during the forecast period. Based on the geographic regions, our experts anticipate that Europe will be the fastest-growing segment during the forecast period. The Europe region will grow at a CAGR ranging from 1% to 0.3% by 2022.

Acoording to The New Market Research Please Check The Updated Report on Gastrointestinal Drugs Market

KEY BENEFITS OF THE REPORT

  • Thorough understanding of the dynamics influencing the various segments of this market
  • Detailed analysis of the regulatory environment impacting the growth of this market
  • Valuable insights into the key technological and market trends impacting this market

KEY PREMIUM INDUSTRY INSIGHTS

  • The gastrointestinal diseases market is driven by the continuous rise in the incidences of the gastrointestinal diseases worldwide.
  • According to the Gastroenterological Society of Australia, the gastrointestinal diseases such as Crohn’s disease, ulcerative colitis, and inflammatory bowel diseases are increasing in Australia and other countries at a constant rate. Thus, increasing the demand for the gastrointestinal diseases therapeutics, leading to the market growth to great extent.
  • Furthermore, the rising interest of the companies in increasing the investments in the gastrointestinal diseases market will drive the market growth to some extent.
  • Additionally, it is also noticed that the demand or sale of the gastrointestinal drugs is increased in the developing and developed regions, which will act as a potential driver for the market growth.
  • However, development of new alternative therapies to treat the gastrointestinal diseases, coupled with the regulatory restraints to develop the gastrointestinal drugs will hamper the overall market growth.

RESEARCH METHODOLOGY

The research methodology for Scalar Market Research’s gastrointestinal diseases market report utilizes a combination of top-down and bottom-up research formats. Our primary focus on continuous market tracking, rigorous fact-checking, data-triangulation, and multiple layers of quality control ensures high-quality data that can be leveraged for actionable research insights.

To know about the assumptions considered for the study, Download PDF Sample.

MARKET SEGMENTATION

This report analyzes the gastrointestinal diseases market by the following segments:

  • Gastrointestinal Diseases Market, by Drug Category
    • Antacid & Anti-Ulcerant
    • GIT Anti-inflammatory
    • Antiemetic
    • Anti-diarrhoea
    • Other GIT Therapeutics 

KEY MARKET PLAYERS

Key players in the gastrointestinal diseases market include:

  • AstraZeneca
  • Valeant (Salix Pharmaceuticals)
  • Takeda Pharmaceutical Company Limited
  • Shire
  • Johnson & Johnson Private Limited
  • Eisai Co., Ltd.
  • Allergan

GEOGRAPHIC COVERAGE AND ANALYSIS

This granular market research report covers the following geographic regions in great detail:

Gastrointestinal Diseases Market

TRENDING RELATED REPORT

Dermatology Devices Market, by Diagnostic Devices (Dermatoscopes, Microscopes, Imaging Techniques), Treatment Devices (Liposuction, Microdermabrasion, Cryotherapy, Electrosurgical, Light Therapy Devices, Lasers), Applications (Cancer Diagnosis, Wrinkle Removal, Skin Rejuvenation, Skin Resurfacing, Vascular Lesions, Acne, Psoriasis, Hair Removal) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2022


  1. MARKET OVERVIEW
    1. Definitions
    2. Research Methodology
      1. Primary Data
      2. Secondary Data
      3. Machine Learning
      4. Research Scope
      5. Years Considered
      6. Currency & Pricing
    3. Market Segmentation
  2. EXECUTIVE SUMMARY
    1. Market Summary: Global Gastrointestinal Diseases Market
      1. Global Gastrointestinal Diseases Market Size (US$ million), By Drug Category (2016 vs. 2022)
      2. Global Gastrointestinal Diseases Market Size (US$ million), By Geography (2016 vs. 2022)
  3. MARKET DYNAMICS
    1. Drivers
    2. Restraints
    3. Opportunities
    4. Premium Industry Trends
  4. INDUSTRY ANALYSIS
    1. Major Selling Drug Analysis
      1. Global Gastrointestinal Diseases Market Size (US$ million), Major Selling Drug Analysis (2015)
      2. Nexium
      3. Losec/Prilosec
      4. Dexilant
      5. Lialda
      6. Entyvio
      7. Emend
      8. Creon
    2. Pipeline Analysis
      1. Global Gastrointestinal Diseases Market Size (US$ million), Pipeline Drug Analysis (2014 – 2022)
      2. BEKINDA (RHB-104)
      3. RHB-105 (H. pylori)
      4. RHB 104 (GI/Inflammation)
      5. Relamorelin
      6. Viberzi
      7. mAbs Stelara (ustekinumab)
      8. AMG - 714
    3. Key event analysis
  5. GLOBAL GASTROINTESTINAL DISEASES MARKET, BY DRUG CATEGORY
    1. Overview
      1. Global Gastrointestinal Diseases Market Share (%), By Drug Category, 2016 & 2022
      2. Global Gastrointestinal Diseases Market Size with Pipeline Drug Revenue (US$ million), By Drug Category (2014 – 2022)
      3. Global Gastrointestinal Diseases Market Size (US$ million), By Drug Category (2014 – 2022)
      4. Global Gastrointestinal Diseases Market Size (US$ million), By Drug Category, 2016 & 2022
    2. Antacid & Anti-Ulcerant
      1. Global Antacid & Anti-Ulcerant Market Size (US$ million), By Region (2014 – 2022)
    3. GIT Anti-inflammatory
      1. Global GIT Anti-inflammatory Market Size (US$ million), By Region (2014 – 2022)
    4. Antiemetic
      1. Global Antiemetic Market Size (US$ million), By Region (2014 – 2022)
    5. Anti-diarrhoea
      1. Global Anti-diarrhoea Market Size (US$ million), By Region (2014 – 2022)
    6. Other GIT Therapeutics
      1. Global Other GIT Therapeutics Market Size (US$ million), By Region (2014 – 2022)
  6. GLOBAL GASTROINTESTINAL DISEASES MARKET, BY GEOGRAPHY
    1. Overview
      1. Global Gastrointestinal Diseases Market Share (%), By Geography, 2016 & 2022
      2. Global Gastrointestinal Diseases Market Size (US$ million), By Geography (2014 – 2022)
      3. Global Gastrointestinal Diseases Market Size (US$ million), By Geography, 2016 & 2022
    2. North America
      1. North America Gastrointestinal Diseases Market Share (%), By Country, 2016 & 2022
      2. North America Gastrointestinal Diseases Market Size (US$ million), By Country (2014 – 2022)
      3. North America Gastrointestinal Diseases Market Size (US$ million), By Country, 2016 & 2022
      4. North America Gastrointestinal Diseases Market Size (US$ million), By Drug Category (2014 – 2022)
    3. Europe
      1. Europe Gastrointestinal Diseases Market Share (%), By Country, 2016 & 2022
      2. Europe Gastrointestinal Diseases Market Size (US$ million), By Country (2014 – 2022)
      3. Europe Gastrointestinal Diseases Market Size (US$ million), By Country, 2016 & 2022
      4. Europe Gastrointestinal Diseases Market Size (US$ million), By Drug Category (2014 – 2022)
    4. Asia-Pacific
      1. Asia-Pacific Gastrointestinal Diseases Market Share (%), By Country, 2016 & 2022
      2. Asia-Pacific Gastrointestinal Diseases Market Size (US$ million), By Country (2014 – 2022)
      3. Asia-Pacific Gastrointestinal Diseases Market Size (US$ million), By Country, 2016 & 2022
      4. Asia-Pacific Gastrointestinal Diseases Market Size (US$ million), By Drug Category (2014 – 2022)
    5. Rest of the World
      1. Rest of the World Gastrointestinal Diseases Market Share (%), By Country, 2016 & 2022
      2. Rest of the World Gastrointestinal Diseases Market Size (US$ million), By Country (2014 – 2022)
      3. Rest of the World Gastrointestinal Diseases Market Size (US$ million), By Country, 2016 & 2022
      4. Rest of the World Gastrointestinal Diseases Market Size (US$ million), By Drug Category (2014 – 2022)
  7. COMPETITIVE LANDSCAPE
    1. Market Share Analysis
    2. Key Innovators
      1. RedHill
      2. Allergan
      3. Shire
  8. COMPANY PROFILES
    1. AstraZeneca
      1. Overview
      2. Key Strategies
        1. Strong research and development activities
        2. Novel therapeutics in company’s product offering
      3. Recent Developments
    2. Valeant (Salix Pharmaceuticals)
      1. Overview
      2. Key Strategies
        1. Strategic merger and acquisitions
        2. U.S. FDA approvals
        3. Strong positioning in gastrointestinal anti-inflammatory therapeutic segment
      3. Recent Developments
    3. Takeda Pharmaceutical Company Limited
      1. Overview
      2. Key Strategies
        1. Conducting awareness programs
        2. U.S. FDA approval
        3. Expansion of product portfolio through acquisitions
        4. Focus on core geography markets
      3. Recent Developments
    4. Shire
      1. Overview
      2. Key Strategies
        1. Expansion through strategic acquisition
        2. Focus on the development of therapeutics for rare diseases
        3. Expansion of product portfolio through innovation
      3. Recent Developments
    5. Johnson & Johnson Private Limited
      1. Overview
      2. Key Strategies
        1. Focus on product development and regulatory approvals
      3. Recent Developments
    6. Eisai Co., Ltd.
      1. Overview
      2. Key Strategies
        1. Pricing strategy to emphasize affordability
        2. Focus on emerging markets
        3. Transformation of product portfolio
      3. Recent Developments
    7. Allergan
      1. Overview
      2. Key Strategies
        1. Strategic merger and acquisitions
      3. Recent Developments
  9. APPENDIX
    1. Acronyms
    2. Related Reports

List of Tables

 

Table 1.                Definitions

Table 2.                Market Summary: Global Gastrointestinal Diseases Market

Table 3.                Global Gastrointestinal Diseases Market Drivers

Table 4.                Global Gastrointestinal Diseases Market Restraints

Table 5.                Global Gastrointestinal Diseases Market Size (US$ million), Major Selling Drug Analysis (2015)

Table 6.                Global Gastrointestinal Diseases Market Size (US$ million), Pipeline Drug Analysis (2014 – 2022)

Table 7.                Key event analysis- Global Gastrointestinal Diseases Market

Table 8.                Global Gastrointestinal Diseases Market Size with Pipeline Drug Revenue (US$ million), By Drug Category (2014 – 2022)

Table 9.                Global Gastrointestinal Diseases Market Size (US$ million), By Drug Category(2014 – 2022)

Table 10.              Global Antacid & Anti-Ulcerant Market Size (US$ million), By Region (2014 – 2022)

Table 11.              Global GIT Anti-inflammatory Market Size (US$ million), By Region (2014 – 2022)

Table 12.              Global Antiemetic Market Size (US$ million), By Region (2014 – 2022)

Table 13.              Global Anti-diarrhoea Market Size (US$ million), By Region (2014 – 2022)

Table 14.              Global Other GIT Therapeutics Market Size (US$ million), By Region (2014 – 2022)

Table 15.              Global Gastrointestinal Diseases Market Size (US$ million), By Geography(2014 – 2022)

Table 16.              North America Gastrointestinal Diseases Market Size (US$ million), By Country (2014 – 2022)

Table 17.              Gastrointestinal Diseases Market in U.S., Market Size (US$ million) and Y-o-Y Growth (%)

Table 18.              Gastrointestinal Diseases Market in Rest of Canada, Market Size (US$ million) and Y-o-Y Growth (%)

Table 19.              North America Gastrointestinal Diseases Market Size (US$ million), By Drug Category(2014 – 2022)

Table 20.              Europe Gastrointestinal Diseases Market Size (US$ million), By Country (2014 – 2022)

Table 21.              Gastrointestinal Diseases Market in Germany, Market Size (US$ million) and Y-o-Y Growth (%)

Table 22.              Gastrointestinal Diseases Market in France, Market Size (US$ million) and Y-o-Y Growth (%)

Table 23.              Gastrointestinal Diseases Market in Rest of the Europe, Market Size (US$ million) and Y-o-Y Growth (%)

Table 24.              EuropeGastrointestinal DiseasesMarket Size (US$ million), By Drug Category (2014 – 2022)

Table 25.              Asia-Pacific Gastrointestinal Diseases Market Size (US$ million), By Country (2014 – 2022)

Table 26.              Gastrointestinal Diseases Market in India, Market Size (US$ million) and Y-o-Y Growth (%)

Table 27.              Gastrointestinal Diseases Market in China, Market Size (US$ million) and Y-o-Y Growth (%)

Table 28.              Gastrointestinal Diseases Market in Rest of the Asia-Pacific, Market Size (US$ million) and Y-o-Y Growth (%)

Table 29.              Asia-Pacific Gastrointestinal DiseasesMarket Size (US$ million), By Drug Category(2014 – 2022)

Table 30.              Rest of the World Gastrointestinal Diseases Market Size (US$ million), By Country (2014 – 2022)

Table 31.              Gastrointestinal Diseases Market in Latin America, Market Size (US$ million) and Y-o-Y Growth (%)

Table 32.              Gastrointestinal Diseases Market in Middle East and Africa, Market Size (US$ million) and Y-o-Y Growth (%)

Table 33.              Rest of the World Gastrointestinal Diseases Market Size (US$ million), By Drug Category (2014 – 2022)

Table 34.              AstraZeneca – Company Overview

Table 35.              Valeant – Company Overview

Table 36.              Takeda Pharmaceutical Company Limited – Company Overview

Table 37.              Shire – Company Overview

Table 38.              Johnson & Johnson Private Limited – Company Overview

Table 39.              Eisai Co., Ltd. – Company Overview

Table 40.              Allergan – Company Overview

Table 41.              Global Gastrointestinal Diseases Market Trend

Table 42.              List of Acronyms

List of Figures

 

Figure 1.               Research Methodology

Figure 2.               Gastrointestinal Diseases Market, By Drug Category

Figure 3.               Gastrointestinal Diseases Market, By Geography

Figure 4.               Gastrointestinal Diseases Market Segmentation by Regions

Figure 5.               Global Gastrointestinal Diseases Market Size (US$ million), By Drug Category (2016 vs. 2022)

Figure 6.               Global Gastrointestinal Diseases Market Size (US$ million), By Geography (2016 vs. 2022)

Figure 7.               Global Gastrointestinal Diseases Market Share (%), By Drug Category, 2016 & 2022

Figure 8.               Global Gastrointestinal Diseases Market Size (US$ million), By Drug Category, 2016 & 2022

Figure 9.               Global Gastrointestinal Diseases Market Share (%), By Geography, 2016 & 2022

Figure 10.            Global Gastrointestinal Diseases Market Size (US$ million), By Geography, 2016 & 2022

Figure 11.            North America Gastrointestinal Diseases Market Share (%), By Country, 2016 & 2022

Figure 12.            North America Gastrointestinal Diseases Market Size (US$ illion), By Country, 2016 & 2022

Figure 13.            Europe Gastrointestinal Diseases Market Share (%), By Country, 2016 & 2022

Figure 14.            Europe Gastrointestinal Diseases Market Size (US$ million), By Country, 2016 & 2022

Figure 15.            Asia-Pacific Gastrointestinal Diseases Market Share (%), By Country, 2016 & 2022

Figure 16.            Asia-Pacific Gastrointestinal Diseases Market Size (US$ million), By Country, 2016 & 2022

Figure 17.            Rest of the World Gastrointestinal Diseases Market Share (%), By Country, 2016 & 2022

Figure 18.            Rest of the World Gastrointestinal Diseases Market Size (US$ million), By Country, 2016 & 2022

Figure 19.            Market Share Analysis of Key Players

Please submit your enquiry below so our representative can get in touch with you
*
*
*
*
*
*

USA - CANADA TOLL FREE
+1-800-213-5170

EMAIL
sales@scalarmarketresearch.com

Benefits of Buying From Scalar

Unparalleled Expertise

Our industry experts hold inimitable know-how across wide range of industry verticals

Assured Quality

We deliver high-quality, real-time and data-driven industry insights to our clients

24x7 Analyst Support

We offer pre-purchase and post-purchase support from our industry experts

Privacy & Security

All your personal information and confidential details are safe and secure with us